Skip to main content
. 2011 Oct;164(3):992–1007. doi: 10.1111/j.1476-5381.2011.01390.x

Table 2.

Kinetically derived parameters from the in vitro non-equilibrium binding kinetic data and the in vivo derived EC50

In vitro kinetic parameters Dissociation half-life (h) In vivo
Compound Kd (nM) kon (M−1·min−1) koff (min−1) EC50 (nM)
SN003 (tracer) 3.64 ± 0.59 7.72e6± 1.6e6 0.026 ± 0.004 0.44 ND
SN003 5.62 ± 0.53 6.2e6± 8.9e5 0.033 ± 0.004 0.35 ND
PF-4325743 8.22 ± 1.48 4.06e6± 4.6e5 0.0316 ± 0.004 0.37 ND
PF-4659901 4.24 ± 1.2 7.88e6± 1.8e6 0.028 ± 0.008 0.41 ND
PF-4734666 3.06 ± 0.39 4.6e6± 5.1e5 0.0146 ± 0.003 0.79 13.4 ± 0.002
DMP904 0.275 ± 0.07 1.47e7± 1.4e6 0.0038 ± 0.001 3.04 ND
R121919 0.549 ± 0.15 3.69e6± 6.1e5 0.0019 ± 0.0005 6.08 0.290 ± 0.0003
PF-4850890 0.734 ± 0.17 2.79e6± 6.4e5 0.0017 ± 0.0002 6.79 1.48 ± 0.002

Mean values ± SEM; n = 5–7 per compound.

Kd = equilibrium dissociation constant, kon = association rate constant, koff = dissociation rate constant, Dissociation half life = time for half the compound to dissociate from the receptor (calculated by ln2/koff), EC50 = concentration that causes 50% occupancy in vivo, ND = not determined.